ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
A Study of the Safety and Effectiveness of Different Doses of 1592U89 in HIV-Infected Patients

This study has been completed.
Study NCT00002390.   Last updated on June 23, 2005.   Information provided by NIH AIDS Clinical Trials Information Service
Please refer to this study by its ClinicalTrials.gov identifier: NCT00002390


Locations
France
Hopital de Purpan / CHU de Rangueil / Medecine Interue    
      Toulouse Cedex, France
Hopital de Purpan / Service du Professeur Auvergnat    
      Toulouse Cedex, France
Groupe Hospitalier Bichat-Claude Bernard    
      Paris Cedex 18, France
Group Hospier Pitie-Salpetriere / Maladies Infec et Trop    
      Paris Cedex 13, France
Germany
Universitat Erlangen    
      Erlangen, Germany
Universitatsklinikurn Frankfurt    
      Frankfurt, Germany

Sponsors and Collaborators
Glaxo Wellcome


U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act
U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services



Links to all studies - primarily for crawlers